Top Page
Nuix Ltd.
(Sydney:NXL)
Nuix Ltd. (NXL) vs. iShares MSCI Australia ETF (EWA)
Nuix Ltd. Business Overview & Revenue Model
Nuix Ltd. Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 221.51M | 221.50M | 220.62M | 182.47M | 152.31M | 176.07M |
| Gross Profit | 199.66M | 199.23M | 198.97M | 119.13M | 98.29M | 126.14M |
| EBITDA | 53.91M | 56.02M | 61.46M | 35.56M | 11.95M | 27.42M |
| Net Income | -9.21M | -9.21M | 5.03M | -5.59M | -22.79M | -1.41M |
Balance Sheet | ||||||
| Total Assets | 393.43M | 393.43M | 397.08M | 428.19M | 421.66M | 405.45M |
| Cash, Cash Equivalents and Short-Term Investments | 39.97M | 39.97M | 38.03M | 29.59M | 46.85M | 70.86M |
| Total Debt | 5.02M | 5.02M | 11.16M | 11.12M | 13.65M | 11.36M |
| Total Liabilities | 102.63M | 102.63M | 110.85M | 157.34M | 152.59M | 124.38M |
| Stockholders Equity | 290.80M | 290.80M | 286.69M | 270.84M | 269.07M | 281.07M |
Cash Flow | ||||||
| Free Cash Flow | 25.27M | 25.27M | 49.60M | -5.97M | -14.63M | -24.51M |
| Operating Cash Flow | 26.85M | 26.85M | 50.34M | 32.56M | 30.12M | 10.80M |
| Investing Cash Flow | -22.84M | -22.84M | -38.45M | -45.42M | -51.61M | -35.31M |
| Financing Cash Flow | -3.57M | -3.57M | -3.45M | -4.29M | -2.73M | 58.10M |
Nuix Ltd. Technical Analysis
Nuix Ltd. Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | AU$641.42M | 38.09 | 12.02% | 4.18% | 4.03% | 31.66% | |
71 Outperform | AU$1.21B | 16.30 | 65.33% | 9.71% | 25.67% | 744.90% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | AU$537.73M | 90.75 | 10.18% | 0.44% | 17.12% | 311.38% | |
55 Neutral | AU$1.10B | 387.50 | <0.01% | ― | -29.99% | -66.84% | |
43 Neutral | AU$615.77M | -65.71 | -3.19% | ― | 0.40% | -280.65% |
Nuix Ltd. Corporate Events
Nuix Ltd. has announced its acquisition of Linkurious, a Paris-based company specializing in graph-powered AI decision platforms. This strategic move aims to enhance Nuix’s capabilities in data visualization and graph technology, offering immediate value to its customers. The acquisition, valued at up to €20 million, will be funded through a combination of debt and cash reserves, with completion expected in early 2026. This integration is anticipated to create growth opportunities through expanded sales and distribution, leveraging Linkurious’s expertise and customer base across North America, Europe, and Asia-Pacific.
Nuix Limited announced a correction regarding the cessation date of Mr. Jeffrey Bleich as a director, which was inaccurately reported in a previous document. The corrected date of Mr. Bleich’s departure is 19 November 2025. This update ensures accurate corporate governance records and reflects the company’s commitment to transparency.
Nuix Ltd. announced the resignation of Jeffrey Laurence Bleich from his position as a director, effective October 20, 2025. Bleich held 135,000 ordinary shares directly and an additional 10,000 shares through the Jeffrey and Rebecca Bleich Living Trust. This change in the board may impact the company’s strategic direction and stakeholder confidence.
UBS Group AG and its related bodies corporate have ceased to be substantial shareholders of Nuix Ltd. as of November 17, 2025. This change in shareholding could impact Nuix’s market perception and investor confidence, as UBS’s exit may signal shifts in strategic interests or assessments of Nuix’s market position.
Nuix Limited, a global software company, announced the results of its Annual General Meeting where all resolutions were passed successfully. Key resolutions included the re-election of directors and the approval of the Nuix Global Employee Share Award Plan, indicating strong shareholder support and strategic alignment for future growth.
Nuix Limited held its 2025 Annual General Meeting, where the Chairman and Interim CEO addressed shareholders. The company provided a trading update, projecting a full-year Annual Contract Value (ACV) range of $240 million to $260 million, with a focus on business transformation and growth driven by Nuix Neo. The company aims for revenue growth to outpace operating cost growth and expects to maintain positive underlying cash flow for the year.
Nuix Ltd. announced the cessation of Jonathan Rubinsztein as a director, effective October 31, 2025. This change in leadership may impact the company’s strategic direction and stakeholder relations, given Rubinsztein’s significant holdings in the company, including over 2 million fully paid ordinary shares and performance rights.
Nuix Limited has announced a proposed amendment to its Constitution to allow for virtual-only shareholder meetings, aligning with recent legislative changes. This amendment is designed to provide flexibility in meeting formats, particularly in response to health and safety concerns or government restrictions, without affecting the validity of existing proxy votes for the upcoming Annual General Meeting.
Nuix Ltd. has announced the issuance of 3,779 performance rights under an employee incentive scheme. These securities are unquoted and subject to transfer restrictions until the end of the restriction period. This move is part of Nuix’s strategy to incentivize employees, potentially impacting its operational efficiency and market positioning by aligning employee interests with company performance.
Nuix Limited has announced a late lodgement of an Appendix 3Y, which details a change in the director’s interest notice for Mr. Jonathan Rubinsztein. The delay was due to an administrative oversight, and the company has assured that this was an isolated incident. The acquisition of shares was a result of the vesting of performance rights, previously disclosed in August 2025. Nuix emphasizes its commitment to compliance with ASX Listing Rules and believes its current practices are sufficient to prevent future occurrences.
Nuix Limited has announced the withdrawal of two resolutions related to performance rights for the CEO, following the decision of CEO Jonathan Rubinsztein to step down at the end of October 2025. This decision will not impact the validity of proxy forms or other business items at the upcoming AGM, indicating a smooth transition in leadership without affecting shareholder proceedings.
Nuix Limited has announced the appointment of John Ruthven as Interim CEO, effective November 3, 2025, following the departure of Jonathan Rubinsztein. Ruthven, with extensive experience in the software and IT services industries, will lead the company for up to 12 months while a global search for a permanent CEO is conducted. This leadership change aims to maintain Nuix’s strong market position and support its strategic goals during the transition period.
Nuix Limited announced that its CEO, Jonathan Rubinsztein, will step down at the end of October 2025. Under Rubinsztein’s leadership since December 2021, Nuix has stabilized and transformed its business, aligning with its strategic direction and focusing on growth. The Board appreciates his contributions and plans to appoint an interim CEO while conducting a global search for a new leader, indicating a smooth transition and continued focus on growth.
Nuix Ltd. announced the issuance of 50,000 performance rights under an employee incentive scheme. These securities are unquoted and subject to transfer restrictions until the restriction period ends, reflecting the company’s strategy to incentivize its workforce and align their interests with corporate goals.
Nuix Ltd. announced the cessation of 69,730 securities, which expired without being exercised or converted as of September 30, 2025. This development may impact the company’s capital structure and could influence investor perceptions regarding the company’s financial strategy and market positioning.
Nuix Ltd. has announced that UBS Group AG and its related bodies corporate have ceased to be substantial shareholders in the company as of October 6, 2025. This change could impact Nuix’s shareholder structure and influence its market dynamics, potentially affecting investor confidence and the company’s strategic decisions moving forward.
Nuix Limited has unveiled its strategic direction at the XLR8/25 conference, emphasizing its unique market positioning through advanced processing capabilities and the Nuix Neo Platform. The company is focusing on enhancing AI capabilities and developing new solutions for regulators and horizontal workflows, aiming to expand customer use cases and achieve stronger commercial outcomes. Nuix’s holistic approach to AI and data processing is seen as a cornerstone for future growth, with initiatives like the HB² project and contract analysis showcasing its innovative potential.
Nuix Limited, a prominent player in the investigative analytics software industry, announced a change in the address of its Australian registered office, effective from 30 September 2025. The new address will be Level 29, 1 Market Street, Sydney, NSW 2000. This move is part of the company’s operational updates and has been authorized by the Company Secretary, reflecting Nuix’s ongoing commitment to maintaining its corporate infrastructure.